Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current UTMD market cap is 221.03M. The company's latest EPS is USD 4.9047 and P/E is 13.29.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.87M | 12.51M | 12.33M | 11.34M | 10.4M |
| Operating Income | 4.43M | 3.97M | 3.94M | 3.88M | 3.44M |
| Net Income | 4.2M | 3.94M | 4.29M | 3.96M | 3.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.9M | 42.18M | 49.05M | 52.28M | 50.22M |
| Operating Income | 17.63M | 13.71M | 18.88M | 19.79M | 16.78M |
| Net Income | 14.73M | 10.8M | 14.79M | 16.47M | 16.64M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 130.48M | 131.24M | 135.46M | 135.44M | 130.03M |
| Total Liabilities | 8.71M | 7.54M | 7.15M | 7.7M | 5.98M |
| Total Equity | 121.76M | 123.7M | 128.31M | 127.74M | 124.05M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 109.79M | 111.75M | 115.64M | 123.87M | 135.46M |
| Total Liabilities | 8.69M | 8.92M | 8.5M | 9.62M | 7.15M |
| Total Equity | 101.09M | 102.82M | 107.14M | 114.25M | 128.31M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 11.83M | 16.95M | 22.28M | 5.28M | 8.04M |
| Investing | -363k | -549k | -639k | 5k | -110k |
| Financing | -2.06M | -3.09M | -4.17M | -3.98M | -11.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 17.06M | 20.14M | 21.2M | 21.15M | 22.28M |
| Investing | -21.54M | -860k | -552k | -818k | -639k |
| Financing | -4.23M | -10.73M | -10.91M | -5.48M | -4.17M |
| Market Cap | 221.03M |
| Price to Earnings Ratio | 13.29 |
| Price to Sales Ratio | 4.4 |
| Price to Cash Ratio | 2.38 |
| Price to Book Ratio | 1.72 |
| Dividend Yield | 1.87% |
| Shares Outstanding | 3.39M |
| Average Volume (1 week) | 19.42k |
| Average Volume (1 Month) | 24.99k |
| 52 Week Change | -21.48% |
| 52 Week High | 87.21 |
| 52 Week Low | 60.40 |
| Spread (Intraday) | 17.73 (25.33%) |
| Company Name | Utah Medical Products Inc |
| Address |
7043 south 300 west midvale, utah 84047 |
| Website | https://www.utahmed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
